AI assistant
Sending…
Elevance Health, Inc. — Director's Dealing 2021
Mar 3, 2021
29933_dirs_2021-03-03_b278d57d-7966-4976-bba4-879b2380b698.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-03-01
Reporting Person: STARK LEAH (EVP & CHRO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | F | 158 | $311.48 | Disposed | 11794 | Direct |
| 2021-03-01 | Common Stock | A | 1806 | — | Acquired | 13600 | Direct |
| 2021-03-02 | Common Stock | F | 715 | $311.66 | Disposed | 12885 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Employee Stock Option (Right to Buy) | $311.48 | A | 7414 | Acquired | 2031-03-01 | Common Stock (7414.0) | Direct |
Footnotes
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents restricted share units. Restrictions lapse as follows: 602 shares each on 3/1/2022, 3/1/2023 and 3/1/2024.
F3: The option represents a right to purchase a total of 7,414 shares, and is exercisable in three annual installments, with two installments of 2,471 shares each and one installment of 2,472 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.
More from Elevance Health, Inc.
Interim / Quarterly Report
2026
Apr 22
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 6
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Jan 28
Director's Dealing
2026
Jan 14